Literature DB >> 32038882

Ollier disease: the first report in Syria.

Yaseen Dhemesh1, Talha Tawekji1, Mohammad-Nasan Abdul-Baki1, Ghazal Abi-Zamr2, Sawssan Ali3.   

Abstract

Ollier disease is a rare nonhereditary skeletal disorder, characterized by multiple enchondromas, which are noncancerous growth of cartilage. In this report, we present a case of Ollier disease in a 10-year-old Syrian boy. The patient presented with multiple boney masses on hands; he had a history of pathological fractures when he was 5, which caused crippling. We analyzed the clinical, radiographical and pathological characteristics of our patient, which helped us to reach the final diagnosis. Ollier disease is a benign bone tumor, but it has a risk of malignant transformation into chondrosarcoma. The aim of this report is to document the presence of Ollier disease in Syria to help other Syrian physicians considering this disease in the differential diagnosis if they face similar presentations.
© The Author(s) 2020. Published by Oxford University Press.

Entities:  

Keywords:  dermatology; oncology; pediatrics

Year:  2020        PMID: 32038882      PMCID: PMC6996042          DOI: 10.1093/omcr/omz145

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

Ollier disease was first described in 1898; it is a skeletal disorder characterized by multiple enchondromas, which are cartilage nodules that develop within the bones. The prevalence of Ollier disease is 1 in 100 000 and the pathogenesis of the disease is unknown. The most common complaint is cosmetic deformity due to multiple swellings on hands and feet, and most patients present with limping caused by asymmetric shortening of an extremity [1, 2]. Diagnosis of Ollier disease depends on clinical, radiographic and pathologic findings. Enchondroma in Ollier disease has a potential risk of malignant transformation into chondrosarcoma. Treatment options have limited effect, but when complications exist, surgery is recommended [3].

CASE REPORT

A 10-year-old Syrian boy presented to pediatric hospital complaining of limping with multiple painless asymmetric nodular swelling of proximal phalanges bones (Fig. 1A). He had a history of multiple fractures in long bones characterized by abnormal healing started when he was 5. Physical examination revealed that intelligence was unaffected, vital signs were normal and the patient also developed progressive skeletal distortions in proximal and distal phalanx of hands with a slight functional limitation, enlargement in distal end of both right forearm and right leg compared with left ones. We noticed shortness of right lower limb, which caused crippling (Fig. 1B). Examination of his parents was normal. The patient status was stable at his last review and he is being followed up annually.
Figure 1

Clinical photographs of both hands showing multiple swellings (A) and shortness of right lower limb (B).

Clinical photographs of both hands showing multiple swellings (A) and shortness of right lower limb (B). We collected blood cell data during his first visit to the hospital. All laboratory test results are demonstrated in Table 1.
Table 1

Laboratory tests on admission.

VariableResultNormal range
WBC9600/μl4400–11 000/μl
Neutrophils76%40–70%
Lymphocytes17%20–40%
HB13 g/dl13–16 g/dl
RBCs MCV79 fl82–96 fl
PLT293 μl150–450 × 103/μl
Cl104 mmol/l95–105 mmol/l
Na138 mmol/l135–148 mmol/l
K3.83 mmol/l3.5–5.0 mmol/l
Ca10.2 mg/dl8.5–10.5 mg/dl
P4.44 mg/dl2.5–4.5 mg/dl
Uric acid3.48 mg/dl3.4–7.0 mg/dl
ALP (Alkaline phosphatase)297 IU/l44–147 IU/l
Urea25 mg/dl10–50 mg/dl
Creatinine0.67 mg/dl0.7–1.36 mg/dl
ALT13 IU/l8–20 IU/l
AST24 IU/l8–20 IU/l
ESR24 mm/h0–20 mm/h
TP (total protein)7.61 g/dl6–8 g/dl
CRP0.31 mg/l<2 mg/l
Laboratory tests on admission. A plain radiograph was performed, showing multiple bone lesions in extremities, whereas skull and chest were normal (Fig. 2).
Figure 2

Multiple radiolucent, well-defined, lytic lesions are seen in metacarpal and phalanges bones (A), distal end of right leg and right femur (B and C) and proximal end of right femur (D), in keeping with multiple enchondromas.

We performed a biopsy from nodules in the right hand to exclude malignancy (Fig. 3).
Figure 3

Microscopic examination of enchondromas showed hyaline cartilage, osseous tissue and trabeculae (A) and chondrocytes with cytological atypia (B).

DISCUSSION

Enchondromas are neoplasms of hyaline cartilage, which are a type of benign bone tumor family. The most affected bones are the short tubular bones of the hands and feet, but it may present in long bones such as the femur, humerus and tibia. Ribs and flat bones are rarely affected. If there are multiple enchondromas, we call this condition enchondromatosis, also known as Ollier disease [1, 4]. Ollier disease was first described at the end of the 19th century, and in 1978, Spranger et al. put a classification of enchondromatosis based on radiographic appearance, anatomic site and mode of inheritance. The result was six subtypes of enchondromatosis: Ollier disease is classified as Spranger type I and Spranger type II is Maffucci syndrome, which is the same as Ollier disease but with hemangiomas [5]. Ollier disease is usually non-familial disorder, and therefore, it appears to occur spontaneously. To date, no evidence suggests that it is inherited. The atypical distribution of lesions in the disease suggests that postzygotic somatic mosaic mutations are the cause of the malformation of endochondral bone, such as heterozygous mutations in the isocitrate dehydrogenase [6]. Also heterozygous mutations and missense mutations in PTH/PTHrP type I receptor (PTHR1) or dysregulation in the Indian hedgehog signaling pathway (IHH) may cause growth of enchondroma in Ollier disease patients, as these two play a role in regulating chondrocyte differentiation, proliferation and maturation especially during endochondral ossification [7]. The diagnosis of Ollier disease is based on clinical manifestations and specific radiographic findings, but histopathologic examinations have limited influence, unless malignancy is suspected [8]. The lesions may affect multiple bones and generally occur bilaterally, with unilateral predominance leading to asymmetric distribution, which cause leg discrepancy and pathologic fractures. Patients usually present with palpable painless bony masses, which can be in various size, location, number and age of onset [1]. Plain radiography is highly important in the evaluation of the disease and usually provides adequate information. Radiographic findings include multiple, radiolucent, homogeneous lesions with a well-defined margin. When the lesions increase in size and cause pain, ultrasound, magnetic resonance imaging and scintigraphy are recommended [2, 3]. The enchondroma is composed of benign hyaline cartilage nodules with well-defined margins. Histopathologic examination differentiates between benign enchondromas and malignant chondrosarcomas [9]. The differential diagnosis may include hereditary multiple exostosis. The osteochondromas seen in hereditary multiple exostosis are located at the bone surface, whereas enchondromas are located in the center of bones [1]. Treatment of Ollier disease is usually conservative. Surgical intervention is performed in cases of limb-length discrepancy, pathological fracture and malignant transformation [10]. The prognosis of Ollier disease is difficult to assess as there can be a variation in the size, number and location. There is a risk of malignant transformation, in these case a careful lifelong follow up is necessary [1]. Multiple radiolucent, well-defined, lytic lesions are seen in metacarpal and phalanges bones (A), distal end of right leg and right femur (B and C) and proximal end of right femur (D), in keeping with multiple enchondromas. Microscopic examination of enchondromas showed hyaline cartilage, osseous tissue and trabeculae (A) and chondrocytes with cytological atypia (B). This is the first case reported of Ollier disease in Syria. This case raises the awareness between Syrian physicians to discover more cases of Ollier disease, which in turn help patients to obtain pre-diagnosis and better therapy outcome.
  8 in total

Review 1.  Ollier Disease: Pathogenesis, Diagnosis, and Management.

Authors:  Avinash Kumar; Vijay Kumar Jain; Minakshi Bharadwaj; Rajendra Kumar Arya
Journal:  Orthopedics       Date:  2015-06       Impact factor: 1.390

2.  A mutant PTH/PTHrP type I receptor in enchondromatosis.

Authors:  Sevan Hopyan; Nalan Gokgoz; Raymond Poon; Robert C Gensure; Chunying Yu; William G Cole; Robert S Bell; Harald Jüppner; Irene L Andrulis; Jay S Wunder; Benjamin A Alman
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

3.  Two peculiar types of enchondromatosis.

Authors:  J Spranger; H Kemperdieck; H Bakowski; J M Opitz
Journal:  Pediatr Radiol       Date:  1978-12-04

4.  Ollier disease: two case reports and a review of the literature.

Authors:  Jing-Ping Wang; Zhou-Yi Xu; Zheng-Qi Bao; Xiu-Song Dai; Li Ma; Nan Yao; Z Peter Wang; Yi-Sheng Tao; Da-Min Chai
Journal:  Am J Transl Res       Date:  2018-11-15       Impact factor: 4.060

Review 5.  Hereditary multiple exostoses and enchondromatosis.

Authors:  Stéphanie Pannier; Laurence Legeai-Mallet
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

6.  Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.

Authors:  Twinkal C Pansuriya; Ronald van Eijk; Pio d'Adamo; Maayke A J H van Ruler; Marieke L Kuijjer; Jan Oosting; Anne-Marie Cleton-Jansen; Jolieke G van Oosterwijk; Sofie L J Verbeke; Daniëlle Meijer; Tom van Wezel; Karolin H Nord; Luca Sangiorgi; Berkin Toker; Bernadette Liegl-Atzwanger; Mikel San-Julian; Raf Sciot; Nisha Limaye; Lars-Gunnar Kindblom; Soeren Daugaard; Catherine Godfraind; Laurence M Boon; Miikka Vikkula; Kyle C Kurek; Karoly Szuhai; Pim J French; Judith V M G Bovée
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 41.307

Review 7.  Ollier disease.

Authors:  Caroline Silve; Harald Jüppner
Journal:  Orphanet J Rare Dis       Date:  2006-09-22       Impact factor: 4.123

Review 8.  Benign tumours of the bone: A review.

Authors:  David N Hakim; Theo Pelly; Myutan Kulendran; Jochem A Caris
Journal:  J Bone Oncol       Date:  2015-03-02       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.